The Guardian - Pharmaceutical Industry

JANUARY 28, 2024

Dr Art Van Zee set out in the early 2000s to tell anyone who would listen how a powerful opioid was destroying lives. Two decades later, he’s still in disbelief When Dr Art Van Zee finally understood the scale of the disaster looming over his corner of rural Virginia, he naively imagined the drug industry would be just as alarmed. So the longest serving doctor in the struggling former mining town of St Charles set out in the early 2000s to tell pharmaceutical executives, federal regulators, Cong

100

100

pharmaphorum

JANUARY 28, 2024

The CHMP has rejected marketing approvals for two drugs from Neuraxpharm and Apellis, but the pharma companies say they will appeal

110

110

The FDA Law Blog

JANUARY 28, 2024

By Jeffrey N. Gibbs & Steven J. Gonzalez — In a new publication in the Washington Legal Foundation’s (WLF) Legal Backgrounder , we argue that FDA’s recent proposed rule regulating Laboratory Developed Tests (LDTs) is vulnerable to legal challenge, once finalized. FDA’s proposed rule has every hallmark of a case subject to the “major questions doctrine,” according to which agency action must be support by clear congressional authorization.

FDA 64

FDA 64

Med Ed 101

JANUARY 28, 2024

Many often wonder when to use prednisone versus prednisolone and why we may see one over the other prescribed in practice. They are not the same medication and have their differences, but they also share a lot of similarities. To make it simple it is often about what is the easiest dosage form for the […] The post Prednisone Versus Prednisolone appeared first on Med Ed 101.

Dosage 52

Dosage 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Roots Analysis

JANUARY 28, 2024

Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. Not only in healthcare, but various industries have also adopted big data to enhance their capabilities, improve customer experiences, and strengthen their brand reputation, thereby contributing to overall growth of the company.

Health and Personal Care Stores 40

Health and Personal Care Stores Medical Records Hospitals 40